ClearPoint Neuro Inc vs Kingsoft Cloud Holdings Limited — how do they compare? ClearPoint Neuro Inc trades at $15.69 (market cap $478.63M), while Kingsoft Cloud Holdings Limited trades at $10.03 (market cap $2.93B). The key difference: Kingsoft Cloud Holdings Limited is far larger — about 6.1× ClearPoint Neuro Inc's market cap, and ClearPoint Neuro Inc is trading nearer its 52-week high, Kingsoft Cloud Holdings Limited nearer its low. Which is the better fit depends on your goals.
| CLPT | KC | |
|---|---|---|
Market Cap | $478.63M | $2.93B |
Sector | Health | Technology |
52-Week High | $29.60 | $18.21 |
52-Week Low | $8.66 | $8.58 |
Enterprise Value | $506.63M | $3.23B |
Signals from Pluang's Aura AI — not financial advice
ClearPoint Neuro (CLPT) trades at $16.51, down 5.66% on the day, with a bullish technical signal from moving averages but negative profitability. The company reported record Q1 2026 revenue of $36.97M with 25% organic device growth, though it missed EPS estimates with a $0.32 loss. Recent FDA clearance for the Velocity Alpha surgical drill and a partnership with Sungkyunkwan University highlight expansion efforts in neurosurgical navigation and drug delivery.
Outlook remains speculative with 100% analyst buy ratings anticipating gene therapy commercialization upside, but high execution and regulatory risks persist amid consistent losses and negative margins. The stock's valuation at 11.31x sales reflects growth expectations, yet cash burn from operations requires careful monitoring of financing sustainability.
Kingsoft Cloud (KC) trades at $10.39, down 4.77% today, with a bullish technical signal and strong analyst support (70% buy ratings). Recent quarters show consistent earnings beats, though the company remains unprofitable with a -9.39% net margin. Revenue growth is robust, driven by AI cloud demand, while cash flow from operations improved to $3.80B in 2025. Technical indicators suggest bullish momentum with support near $10 and resistance at $11.
The stock presents a growth opportunity amid China's AI expansion, but profitability challenges and high valuation multiples pose risks. Analyst consensus points to 25.4% upside potential, though execution on margin improvement is critical for sustained gains. Macroeconomic and regulatory factors in China remain key watchpoints for investors.
Trailing returns across standard periods
Latest headlines on both assets
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →Kingsoft Cloud is a leading independent cloud service provider in China. It offers a comprehensive suite of cloud products and solutions tailored for industries like gaming, video streaming, and financial services.
Read more on KC →